...
首页> 外文期刊>The Biochemical Journal >Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases.
【24h】

Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases.

机译:WZ4003和HTH-01-015作为LKB1肿瘤抑制因子激活的NUAK激酶的选择性抑制剂的表征。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The related NUAK1 and NUAK2 are members of the AMPK (AMP-activated protein kinase) family of protein kinases that are activated by the LKB1 (liver kinase B1) tumour suppressor kinase. Recent work suggests they play important roles in regulating key biological processes including Myc-driven tumorigenesis, senescence, cell adhesion and neuronal polarity. In the present paper we describe the first highly specific protein kinase inhibitors of NUAK kinases namely WZ4003 and HTH-01-015. WZ4003 inhibits both NUAK isoforms (IC50 for NUAK1 is 20 nM and for NUAK2 is 100 nM), whereas HTH-01-015 inhibits only NUAK1 (IC50 is 100 nM). These compounds display extreme selectivity and do not significantly inhibit the activity of 139 other kinases that were tested including ten AMPK family members. In all cell lines tested, WZ4003 and HTH-01-015 inhibit the phosphorylation of the only well-characterized substrate, MYPT1 (myosin phosphate-targeting subunit 1) that is phosphorylated by NUAK1 at Ser(445). We also identify a mutation (A195T) that does not affect basal NUAK1 activity, but renders it ~50-fold resistant to both WZ4003 and HTH-01-015. Consistent with NUAK1 mediating the phosphorylation of MYPT1 we find that in cells overexpressing drug-resistant NUAK1[A195T], but not wild-type NUAK1, phosphorylation of MYPT1 at Ser(445) is no longer suppressed by WZ4003 or HTH-01-015. We also demonstrate that administration of WZ4003 and HTH-01-015 to MEFs (mouse embryonic fibroblasts) significantly inhibits migration in a wound-healing assay to a similar extent as NUAK1-knockout. WZ4003 and HTH-01-015 also inhibit proliferation of MEFs to the same extent as NUAK1 knockout and U2OS cells to the same extent as NUAK1 shRNA knockdown. We find that WZ4003 and HTH-01-015 impaired the invasive potential of U2OS cells in a 3D cell invasion assay to the same extent as NUAK1 knockdown. The results of the present study indicate that WZ4003 and HTH-01-015 will serve as useful chemical probes to delineate the biological roles of the NUAK kinases.Registry Number/Name of Substance 0 (Anilides). 0 (Benzodiazepinones). 0 (HTH-01-015). 0 (Heterocyclic Compounds with 4 or More Rings). 0 (Protein Kinase Inhibitors). 0 (Pyrimidines). 0 (Repressor Proteins). 0 (Tumor Suppressor Proteins). 0 (WZ4003). EC 2-7 (Protein Kinases). EC 2-7-1 (NUAK1 protein, human). EC 2-7-1 (STK11 protein, human). EC 2-7-11-1 (NUAK2 protein, human). EC 2-7-11-1 (Protein-Serine-Threonine Kinases).
机译:相关的NUAK1和NUAK2是被LKB1(肝激酶B1)肿瘤抑制激酶激活的蛋白激酶AMPK(AMP激活的蛋白激酶)家族的成员。最近的工作表明,它们在调节关键的生物学过程中起重要作用,包括Myc驱动的肿瘤发生,衰老,细胞粘附和神经元极性。在本文中,我们描述了首批NUAK激酶的高度特异性蛋白激酶抑制剂,即WZ4003和HTH-01-015。 WZ4003抑制两种NUAK同工型(NUAK1的IC50为20 nM,而NUAK2的IC50为100 nM),而HTH-01-015仅抑制NUAK1(IC50为100 nM)。这些化合物显示出极高的选择性,并没有明显抑制包括10个AMPK家族成员在内的139种其他激酶的活性。在所有测试的细胞系中,WZ4003和HTH-01-015抑制唯一被充分表征的底物MYPT1(靶向肌球蛋白磷酸化的亚基1)的磷酸化,该底物被NUAK1在Ser(445)处磷酸化。我们还确定了一个突变(A195T),该突变不影响基础NUAK1的活性,但使其对WZ4003和HTH-01-015的抵抗力均为50倍左右。与介导MYPT1磷酸化的NUAK1一致,我们发现在过度表达抗药性NUAK1 [A195T]而不是野生型NUAK1的细胞中,WZ4003或HTH-01-015不再抑制Ser(445)上MYPT1的磷酸化。我们还证明了向MEF(小鼠胚胎成纤维细胞)施用WZ4003和HTH-01-015可以显着抑制伤口愈合分析中的迁移,其程度与NUAK1基因敲除相似。 WZ4003和HTH-01-015还以与NUAK1基因敲除相同的程度抑制MEF的增殖,并以与NUAK1 shRNA基因敲除相同的程度抑制U2OS细胞。我们发现WZ4003和HTH-01-015在3D细胞侵袭试验中损害了U2OS细胞的侵袭潜能,其破坏程度与NUAK1敲低相同。本研究的结果表明,WZ4003和HTH-01-015将作为有用的化学探针来描述NUAK激酶的生物学作用。登记号/物质0(苯胺)的名称。 0(苯二酮)。 0(HTH-01-015)。 0(具有4个或更多环的杂环化合物)。 0(蛋白激酶抑制剂)。 0(嘧啶)。 0(阻遏蛋白)。 0(肿瘤抑制蛋白)。 0(WZ4003)。 EC 2-7(蛋白激酶)。 EC 2-7-1(NUAK1蛋白,人类)。 EC 2-7-1(STK11蛋白,人类)。 EC 2-7-11-1(NUAK2蛋白,人类)。 EC 2-7-11-1(蛋白质-丝氨酸-苏氨酸激酶)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号